These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 16734625

  • 1. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, Jones T, Burt DS, Van Nest G, Lee SF.
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.
    Alonso S, Reveneau N, Pethe K, Locht C.
    Infect Immun; 2002 Aug; 70(8):4142-7. PubMed ID: 12117922
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES, O'Hagan DT, Illum L, Redhead K.
    FEMS Microbiol Lett; 1993 Mar 01; 107(2-3):211-6. PubMed ID: 8472903
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K, Ginnaga A, Nishihara T, Tsunoda S, Furukawa M, Aihara K, Sakoh M.
    Dev Biol Stand; 1991 Mar 01; 73():223-32. PubMed ID: 1685713
    [Abstract] [Full Text] [Related]

  • 11. Haemagglutination induced by Bordetella pertussis filamentous haemagglutinin adhesin (FHA) is inhibited by antibodies produced against FHA(430-873) fragment expressed in Lactobacillus casei.
    Colombi D, Oliveira ML, Campos IB, Monedero V, Pérez-Martinez G, Ho PL.
    Curr Microbiol; 2006 Dec 01; 53(6):462-6. PubMed ID: 17106803
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
    Jabbal-Gill I, Fisher AN, Rappuoli R, Davis SS, Illum L.
    Vaccine; 1998 Dec 01; 16(20):2039-46. PubMed ID: 9796062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.
    Leininger E, Bowen S, Renauld-Mongénie G, Rouse JH, Menozzi FD, Locht C, Heron I, Brennan MJ.
    J Infect Dis; 1997 Jun 01; 175(6):1423-31. PubMed ID: 9180182
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
    Berstad AKH, Holst J, Frøholm LO, Haugen IL, Wedege E, Oftung F, Haneberg B.
    J Med Microbiol; 2000 Feb 01; 49(2):157-163. PubMed ID: 10670566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.